Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 29, 2019
Systematic review and meta-analysis of small bowel dose-volume and acute toxicity in conventionally-fractionated rectal cancer radiotherapy
Daniel L P Holyoake, Mike Partridge, Maria A Hawkins
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 11, 2017
Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data
Daniel L P Holyoake, Marianne Aznar, Somnath Mukherjee, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 20, 2020
SPARC, a phase-I trial of pre-operative, margin intensified, stereotactic body radiation therapy for pancreatic cancer
Daniel L P Holyoake, Maxwell Robinson, Michael Silva, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 1, 2020
Superior outcomes of nodal metastases compared to visceral sites in oligometastatic colorectal cancer treated with stereotactic ablative radiotherapy
Sean M O'Cathail, Thomas Smith, Rob Owens, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 14, 2016
Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer
Daniel L P Holyoake, Maxwell Robinson, Derek Grose, et al.
BMC Cancer
|
September 14, 2016
A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocol
Daniel L P Holyoake, Elizabeth Ward, Derek Grose, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 29, 2019
Systematic review and meta-analysis of small bowel dose-volume and acute toxicity in conventionally-fractionated rectal cancer radiotherapy
Daniel L P Holyoake, Mike Partridge, Maria A Hawkins
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 11, 2017
Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data
Daniel L P Holyoake, Marianne Aznar, Somnath Mukherjee, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 20, 2020
SPARC, a phase-I trial of pre-operative, margin intensified, stereotactic body radiation therapy for pancreatic cancer
Daniel L P Holyoake, Maxwell Robinson, Michael Silva, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 1, 2020
Superior outcomes of nodal metastases compared to visceral sites in oligometastatic colorectal cancer treated with stereotactic ablative radiotherapy
Sean M O'Cathail, Thomas Smith, Rob Owens, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 14, 2016
Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer
Daniel L P Holyoake, Maxwell Robinson, Derek Grose, et al.
BMC Cancer
|
September 14, 2016
A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocol
Daniel L P Holyoake, Elizabeth Ward, Derek Grose, et al.
Page
of 1